AstraZeneca Stock And 2 UK Shares Screened For Cash Flow Value

With inflation worries, shifting rate expectations and energy driven costs in focus, many investors are turning back to the basics of cash generation and valuation discipline. The Undervalued Stocks Based On Cash Flows screener focuses on companies where projected cash flows, as assessed by SWS DCF valuation, sit above the current share price, suggesting potential mispricing. For investors who want to keep risk grounded in real cash and not just headlines, this can be a useful hunting ground. This article highlights three stocks from the screener that stand out on this cash flow and valuation mix.

AstraZeneca (LSE:AZN)

Overview: AstraZeneca is a global biopharmaceutical company headquartered in Cambridge that discovers, develops, manufactures and sells prescription medicines across oncology, cardiovascular, renal and metabolism, respiratory and immunology, vaccines and immune therapies, and rare diseases.

Operations: AstraZeneca generates essentially all of its revenue, around $60.4b in 2024, from its pharmaceuticals portfolio.

Market Cap: £195.6b

For investors looking at cash flow backed opportunities, AstraZeneca offers a mix of scale and future potential that stands out on this screener, with high return on equity, double digit earnings growth forecasts and a broad late stage oncology and rare disease pipeline supported by AI driven R&D partnerships. At the same time, the stock carries real pressure points, including reliance on blockbuster drugs facing patent and biosimilar risk, regulatory scrutiny on pricing, high debt and recent trial setbacks such as Wainua, all while trading on a P/E above sector averages. The gap between its current price and cash flow based fair value suggests that the key consideration is how these pipeline developments and policy risks balance out over the next few years.

AstraZeneca’s scale and late stage pipeline are only half the story; the real tension is how that growth potential stacks up against pipeline and patent risks. Put the pieces together with the 4 key rewards and 2 important warning signs

Foresight Group Holdings (LSE:FSG)

Overview: Foresight Group Holdings is a London based asset manager that runs infrastructure, renewable energy and private equity funds, giving institutional and retail investors access to real assets and sustainable investment strategies across the UK, Europe and Australia.

Operations: Foresight Group Holdings generates the bulk of its revenue from Real Assets at £114.8m, with Private Equity contributing £50.1m, supported by fees earned primarily in the United Kingdom at £126.4m and Australia at £25.7m.

Market Cap: £506.4m

Foresight Group Holdings appears on a cash flow focused screener because it combines strong fundamentals with a clear thematic focus on energy transition and real assets. Revenue and earnings are both forecast to grow at double digit rates, margins have improved to 27.7%, and returns on equity are already high, even before accounting for more optimistic expectations on future AUM expansion. At the same time, the stock is exposed to fee pressure, rising operating costs and a heavy reliance on UK and European policy support for infrastructure and renewables. Together with an active buyback programme and solid governance, the key issue for investors is how to weigh that growth potential against the regulatory and competition risks inherent in the business model.

Foresight Group Holdings appears to be an accelerating real assets story, but the key question is how growth, margins at 27.7% and fee pressure fit together in one picture. To explore this further, review the analyst forecasts for Foresight Group Holdings

BAE Systems (LSE:BA.)

Overview: BAE Systems is a London headquartered defense and aerospace company that supplies combat aircraft, warships, armored vehicles, munitions, electronics, cyber security and intelligence solutions to governments and defense customers worldwide.

Operations: BAE Systems generates most of its revenue from Electronic Systems at £7.5b, Air at £7.4b, Maritime at £6.6b and Platforms & Services at £5.0b, with smaller contributions from Cyber & Intelligence at £2.4b and Head Quarter activities at £52m, partly offset by £592m of intra group eliminations.

Market Cap: £52.4b

BAE Systems sits on a £75b order backlog tied to long term defense programs across air, maritime and advanced electronics, giving investors visibility on contracted cash flows at a time when many NATO governments are committing to higher defense spending. Some analysts forecast earnings to grow around 11% a year and ROE to rise from 18% toward 22%. The stock is sometimes described as trading below certain cash flow based fair value estimates even though its P/E is reported to be above the sector average. Recent contract wins in electronic warfare, satellites and vehicle protection highlight its exposure to higher value segments. However, concentration in a few major government customers, ESG scrutiny and supply chain bottlenecks remain important risks that investors need to weigh carefully against the potential opportunities.

BAE Systems’ accelerating order book and reported premium P/E raise a key question: is the market fully pricing the contract pipeline, or missing something in the cash flow story covered in the analysis report for BAE Systems?

The three stocks in this article are only a starting point. The full Undervalued Stocks Based On Cash Flows screener surfaces 35 more companies where cash flow potential and current pricing create equally compelling narratives through the Undervalued Stocks Based On Cash Flows screener. Identify and analyze the specific catalysts, risks and cash flow stories that matter to you so you can focus on the highest conviction ideas instead of scrolling through endless tickers.

Take Control of Your Investment Journey

If Foresight Group Holdings or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

New ideas move from quiet accumulation to breakout momentum fast, and once the crowd catches on, the best entry points can be gone. Scan fresh setups and act now.

• Spot companies quietly building momentum before headlines catch up by tracking 7 resilient stocks with low risk scores. These aim to keep downside contained while leaving room for upside.
• Chase real earnings power, not just hype, by scanning the 63 profitable AI stocks that aren't just burning cash already turning AI demand into actual profits and cash flows, while the story is still under the radar for now.
• Ride potential income and capital resilience in one move by checking the curated 3 dividend fortresses. These aim to combine high yields with sturdy financial profiles before valuations start flying.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com